This year marks a major milestone for Linical: 20 years of advancing clinical research. What started as a small team with a shared vision has grown into a global organization known for delivering high-quality, patient-focused research services. As we reflect on two decades of progress, we’re proud of how far we’ve come, and even more excited about where we’re headed next.
From Modest Beginnings to a Global Presence
Our journey began in 2005 with a group of entrepreneurs from a Japanese pharmaceutical company. These founders shared a simple but powerful goal: to improve how clinical trials are conducted. Back then, Linical was a small, agile team working with limited resources but a strong belief that we could do things differently. We focused on building trust with our partners, delivering reliable results, and staying deeply connected to the real-world impact of our work.
Over time, our reputation grew, and so did our capabilities and global footprint. Today, we support trials across all phases and numerous therapeutic areas in more than 30 countries. We offer a full range of services including clinical trial management, drug development strategy, feasibility and site selection, regulatory consulting, biometrics, pharmacovigilance, and regulatory affairs. Despite our growth, we’ve stayed true to our founding principles: quality, integrity, and a commitment to patients.
A Legacy of Clinical Research Excellence
For 20 years, we’ve played a key role in bringing new therapies to market. We’ve supported hundreds of clinical studies across oncology, neurology, immunology, rare diseases, and more. Our work has helped sponsors navigate complex regulatory environments, improve trial efficiency, and gather high-quality data to support regulatory submissions across North America, Europe, and Asia-Pacific (APAC).
What sets Linical apart is not just what we do, but how we do it. We take a collaborative approach to clinical development, working hand-in-hand with sponsors, sites, and clinical research partners. Our teams are known for their flexibility, responsiveness, and scientific expertise. Whether we’re managing a global Phase III trial or helping a biotech startup plan its first-in-human study, we bring the same level of focus and dedication. It is this dedication that’s lead Linical to receive numerous awards over our 20 year tenure, as well as long-standing client relationships spanning decades.
Putting Patients at the Center
Clinical research is about more than data points and endpoints - it’s about people. That’s why we’ve always put patients first. We design trials that reduce patient burden, support diverse enrollment, and make participation as accessible as possible. We work closely with investigators and patient advocacy groups to ensure our protocols reflect real-world needs.
Our decentralized and hybrid trial capabilities have made it easier for patients to participate from home or local clinics. We use technology to streamline consent, data collection, and follow-up while maintaining the human touch that builds trust and drives retention. We believe research should serve patients - not the other way around.
Looking Ahead: The Next Chapter
While we’re proud of what we’ve accomplished, we know our work is far from done. The clinical research landscape is evolving rapidly and embracing new technology, and Linical is committed to staying ahead of the curve. That means continued investment in digital tools, artificial intelligence (AI), advanced analytics, and global infrastructure that supports faster, more inclusive, and more efficient trials.
Additionally, Linical is committed to embracing and following global sustainability recommendations. The Science Based Targets initiative (SBTi) has approved Linical’s greenhouse gas emissions (GHG) near-term reduction targets. This SBTi validation recognizes our efforts to contribute to a sustainable future and positions our company as a leader in environmental responsibility.
We’re also focused on expanding our therapeutic expertise and deepening relationships with key stakeholders including sponsors, sites, regulators, and, most importantly, patients. Our goal is to create a clinical research model that is not only scientifically rigorous, but also compassionate, accessible, and sustainable.
Thank You
Reaching our 20-year milestone wouldn’t have been possible without the people who’ve been part of our journey: our employees, clients, partners, and the many patients who have participated in our trials. We’re grateful for your trust, your collaboration, and your shared commitment to making a difference.
As we look to the future, Linical remains driven by the same mission that started it all: to improve lives through research. Thank you for being part of our story. Here’s to the next 20 years of progress, partnership, and purpose.
You can read more about Linical's 20th anniversary in the following press release.